Inspection Record

Accelera Pharma Canada Inc. doing business as APCI — Health Canada Inspection Findings

Health CanadaInspected 2023-07-04 5 findingsOther quality systemEquipment and facilityStability and storageLaboratory and QC controls

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

The electronic system was not validated for its intended use.

2Equipment and facility

The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.

3Stability and storage

The temperature and/or humidity control was inadequate.

4Other quality system

The written specifications were inadequate.

5Laboratory and QC controls

The quality control department did not undertake all of the required activities.

About this record

Extracted automatically from the document of the Health Canada inspection on 2023-07-04. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Accelera Pharma Canada Inc. doing business as APCI company profile — full history Health Canada documents, 2023 Go to Findings search